M&A Corner
Merck Finalizes $10.8B Prometheus Buy27 Jun 2023
Merck has completed its acquisition of Prometheus Biosciences for approximately $10.8 billion, gaining access to five clinical and pre-clinical candidates... Continue Reading
|
Avanos Medical, Inc. Announces Agreement to Acquire Diros Technology Inc.27 Jun 2023
Avanos Medical, Inc. has announced its acquisition of Diros Technology Inc., a leading manufacturer of radiofrequency (RF) products for treating... Continue Reading
|
Coherus Expands Portfolio with $65M Acquisition of Surface Oncology19 Jun 2023
Coherus Biosciences plans to acquire Surface Oncology, an immuno-oncology company, for up to $65 million. The deal will expand Coherus’... Continue Reading
|
Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio19 Jun 2023
Ironwood Pharmaceuticals and VectivBio Holding have announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act has expired, advancing... Continue Reading
|
Merck Completes Acquisition of Prometheus Biosciences, Inc.19 Jun 2023
Merck has completed its acquisition of Prometheus Biosciences, making it a wholly-owned subsidiary. The acquisition strengthens Merck’s immunology portfolio and... Continue Reading
|
Addentax Group Corp. in Advanced Talks to Acquire Partial Stake in RMB 6 Billion-Valued Recombinant Protein Drugs and Antibody Drugs Bio-pharmaceutical Company, Shanghai Bao Pharmaceutical Company Limited19 Jun 2023
Addentax Group Corp. is in advanced discussions to acquire a partial stake in Shanghai Bao Pharmaceutical Company from its CEO,... Continue Reading
|
Apixio and ClaimLogiq Merge to Minimize Reimbursement Inaccuracies19 Jun 2023
Apixio has completed its merger with ClaimLogiq, forming a combined entity under the Apixio brand. The merger will leverage their... Continue Reading
|
RK Pharma Completes Acquisition of VGYAAN Pharmaceuticals.19 Jun 2023
RK Pharma Inc has successfully acquired VGYAAN Pharmaceuticals LLC, in line with its growth strategy. The acquisition provides RK Pharma... Continue Reading
|
MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates19 Jun 2023
MEI Pharma and Infinity Pharmaceuticals will host a recorded webcast to provide an update on their pending merger and discuss... Continue Reading
|
Validic Acquires Connected Health Platform Trapollo19 Jun 2023
Validic has acquired the assets of Trapollo LLC, a connected health provider, from Cox Communications. The acquisition enhances Validic’s capabilities... Continue Reading
|